Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M48,282Revenue $M20,314Net Margin (%)13.4Z-Score2.4
Enterprise Value $M57,496EPS $1.5Operating Margin %17.4F-Score8
P/E(ttm))17.6Cash Flow Per Share $5.9Pre-tax Margin (%)15.9Higher ROA y-yY
Price/Book2.010-y EBITDA Growth Rate %14.5Quick Ratio0.8Cash flow > EarningsY
Price/Sales2.45-y EBITDA Growth Rate %-1.3Current Ratio1.2Lower Leverage y-yY
Price/Cash Flow7.3y-y EBITDA Growth Rate %70.7ROA % (ttm)5.8Higher Current Ratio y-yY
Dividend Yield %2.1Insider Buy (3m)0ROE % (ttm)12.0Less Shares Outstanding y-yN
Payout Ratio %36.0Shares Outstanding M854ROI % (ttm)0.2Gross Margin Increase y-yY

Gurus Latest Trades with TEVA

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
TEVAVanguard Health Care Fund 2014-09-30 Reduce-0.27%$50.94 - $55.05
($52.93)
$ 56.477%Reduce -26.99%5,362,100
TEVAMichael Price 2014-06-30 Add0.71%$48.69 - $54.06
($51.09)
$ 56.4710%Add 28.73%500,000
TEVARichard Snow 2014-06-30 Add0.21%$48.69 - $54.06
($51.09)
$ 56.4710%Add 6.9%1,826,799
TEVAGeorge Soros 2014-06-30 Reduce-1.59%$48.69 - $54.06
($51.09)
$ 56.4710%Reduce -29.45%7,273,240
TEVAVanguard Health Care Fund 2014-06-30 Reduce-0.73%$48.69 - $54.06
($51.09)
$ 56.4710%Reduce -40.54%7,344,400
TEVANWQ Managers 2014-06-30 Reduce-0.56%$48.69 - $54.06
($51.09)
$ 56.4710%Reduce -19.21%5,085,717
TEVAJames Barrow 2014-06-30 Reduce-0.19%$48.69 - $54.06
($51.09)
$ 56.4710%Reduce -18.5%10,868,770
TEVAKen Heebner 2014-06-30 Sold Out -0.13%$48.69 - $54.06
($51.09)
$ 56.4710%Sold Out0
TEVAGeorge Soros 2014-03-31 Add0.52%$39.88 - $50.22
($45.91)
$ 56.4723%Add 10.67%10,310,041
TEVADavid Dreman 2014-03-31 Add0.15%$39.88 - $50.22
($45.91)
$ 56.4723%Add 24.43%183,323
TEVANWQ Managers 2014-03-31 Add0.14%$39.88 - $50.22
($45.91)
$ 56.4723%Add 5.04%6,294,655
TEVAKen Heebner 2014-03-31 Buy 0.13%$39.88 - $50.22
($45.91)
$ 56.4723%New holding, 95000 sh.95,000
TEVAJohn Keeley 2014-03-31 Buy 0.04%$39.88 - $50.22
($45.91)
$ 56.4723%New holding, 47435 sh.47,435
TEVARichard Snow 2014-03-31 Reduce-0.43%$39.88 - $50.22
($45.91)
$ 56.4723%Reduce -13.55%1,708,890
TEVAGeorge Soros 2013-12-31 Add1.96%$36.59 - $41.7
($39.39)
$ 56.4743%Add 158.2%9,316,000
TEVARichard Snow 2013-12-31 Add0.89%$36.59 - $41.7
($39.39)
$ 56.4743%Add 38.53%1,976,831
TEVAJames Barrow 2013-12-31 Add0.31%$36.59 - $41.7
($39.39)
$ 56.4743%Add 79.64%12,143,563
TEVAMichael Price 2013-12-31 Add0.26%$36.59 - $41.7
($39.39)
$ 56.4743%Add 14.29%400,000
TEVAGeorge Soros 2013-09-30 Buy 1.5%$37.43 - $41.27
($39.03)
$ 56.4745%New holding, 3608000 sh.3,608,000
TEVAVanguard Health Care Fund 2013-09-30 Add0.23%$37.43 - $41.27
($39.03)
$ 56.4745%Add 15.71%13,145,600
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

TEVA is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
TEVA Vanguard Health Care Fund 2014-09-305,362,1000.630.74-26.99%
TEVA Michael Price 2014-06-30500,0000.063.2+28.73%
TEVA Richard Snow 2014-06-301,826,7990.213.3+6.9%
TEVA Ronald Muhlenkamp 2014-06-30176,8550.021.6+0.81%
TEVA Jean-Marie Eveillard 2014-06-3020000
TEVA John Keeley 2014-06-3047,4350.010.05
TEVA Tom Gayner 2014-06-30694,0000.081
TEVA David Dreman 2014-06-30159,0900.020.63-13.22%
TEVA James Barrow 2014-06-3010,868,7701.270.77-18.5%
TEVA NWQ Managers 2014-06-305,085,7170.62.7-19.21%
TEVA George Soros 2014-06-307,273,2400.852.9-29.45%
TEVA Vanguard Health Care Fund 2014-06-307,344,4000.861-40.54%
TEVA Ken Heebner 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


TEVA: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about TEVA :

    Quarterly/Annual Reports about TEVA:

      News about TEVA:

      Articles On GuruFocus.com
      The Gurus’ Favorite Asian Stocks Sep 06 2014 
      George Soros Reveals His Largest Stake Jul 23 2014 
      George Soros Keeps Buying TEVA, EQT, YPF, EGN, CZR And Keeps Selling GOOGL, BA, MSFT, HAR Jul 16 2014 
      Diamond Hill Capital Comments on Teva Pharmaceutical Industries Ltd Jun 26 2014 
      Diamond Hill Select Fund Commentary – First Quarter 2014 Jun 25 2014 
      Top Guru Held Asian Companies of the First Quarter Jun 03 2014 
      George Soros Reports Top Five Stocks May 23 2014 
      Richard Snow's Top Five Highlight Finance and Healthcare Sectors May 14 2014 
      Wrong Marketing Lesson by Big Pharma May 03 2014 
      Should You Buy Actavis? Mar 18 2014 


      More From Other Websites
      Teva ups full-year EPS outlook Oct 30 2014
      Teva raises 2014 profit forecast after strong third quarter Oct 30 2014
      Teva optimistic U.S. top court to rule in favour of MS drug patent Oct 30 2014
      Teva Reports Third Quarter 2014 Results Oct 30 2014
      [$$] Teva Earnings Jump 23% Oct 30 2014
      Teva Pharm Q3 profit beats estimates, raises 2014 EPS forecast Oct 30 2014
      Teva Raises Forecast as Quarterly Profit Beats Estimates Oct 30 2014
      7:07 am Teva Pharma beats by $0.08, reports revs in-line; narrows FY14 EPS above consensus, revs... Oct 30 2014
      Teva Reports Third Quarter 2014 Results Oct 30 2014
      Will Teva (TEVA) Beat Q3 Earnings on Strong Generic Sales? Oct 29 2014
      Your first trade for Tuesday Oct 27 2014
      Lannett Co. Gets Growth Rx In Generic Drugs Group Oct 27 2014
      Ambaraella, Pier One, Pfizer, Teva Pharmaceutical and Ligand Pharmaceuticals highlighted as Zacks... Oct 27 2014
      Will Pfizer (PFE) Disappoint This Earnings Season? Oct 24 2014
      Will Ligand Pharmaceuticals Beat Q3 Earnings Estimates? Oct 24 2014
      Will Bristol-Myers (BMY) Disappoint This Earnings Season? Oct 22 2014
      Will BioMarin (BMRN) Disappoint This Earnings Season? Oct 21 2014
      Will Alexion (ALXN) Earnings Suffer Due to Higher Costs? Oct 21 2014
      Celgene (CELG) Q3 Earnings to Be Overrun by Expenses? Oct 21 2014
      Will Biogen Idec (BIIB) Pull a Surprise this Earnings Season? Oct 20 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK